文献速递甲状腺疾病

2型脱碘酶Thr92Ala多态性与衰老与垂体对甲状腺激素敏感性降低相关

Type 2 Deiodinase Thr92Ala Polymorphism and Aging Are Associated with a Decreased Pituitary Sensitivity to Thyroid Hormone.
PubMed 文献 · Thyroid · 2023-02-13

这项前瞻性研究纳入145例全甲状腺切除后行放射性碘治疗、停用左甲状腺素3周的甲状腺癌患者,并利用小鼠模型检测垂体D2随衰老的变化。研究发现DIO2 Thr92Ala多态性携带者及老年患者停用左甲状腺素后TSH升高反应减弱,提示垂体对甲状腺激素敏感性降低,且与垂体D2水平下降相关。

要点

  • DIO2 Thr92Ala多态性见于56%的受试者,其中Ala/Ala纯合突变占12%。
  • 衰老与停用左甲状腺素后TSH升高幅度呈负相关,该负相关在突变携带者中减弱或消失。
  • 与按年龄预测的理论TSH值相比,WT患者47%、Ala/Thr 70%、Ala/Ala 76%未达目标值(p=0.0036)。

核心结论

  • 衰老相关的甲状腺功能减退时TSH生成下降与垂体D2水平降低相关。
  • DIO2 Ala/Ala纯合多态性与甲状腺功能减退时TSH分泌反应减弱相关,提示垂体对血清甲状腺素变化的敏感性降低。

研究设计与样本

  • 前瞻性研究纳入145例全甲状腺切除后行放射性碘治疗的甲状腺癌患者,停用左甲状腺素3周。
  • 使用小鼠模型检测衰老过程中垂体D2蛋白和mRNA水平。

主要发现

  • 基因分析显示56%的受试者携带DIO2 Thr92Ala多态性:64/145(44%)为纯合野生型(Thr/Thr),64例(44%)为杂合子(Thr/Ala),17例(12%)为纯合突变型(Ala/Ala)。
  • 衰老与停用左甲状腺素期间血清TSH升高呈显著负相关,但该负相关在杂合子中减弱、在纯合突变患者中消失(Thr/Thr r=-0.45,p=0.0002,95%CI -0.63至-0.23;Ala/Thr r=-0.39,p=0.0012,CI -0.60至-0.67;Ala/Ala r=-0.30,p=0.2347,CI -0.70至0.20)。
  • 将每位患者实测TSH与根据年龄预测的理论值比较,TSH未达到推定目标值者在WT患者中占47%、Ala/Thr携带者中占70%、Ala/Ala携带者中占76%(p=0.0036)。
  • 该差异在60岁以上个体中消失,提示D2随衰老下降。
  • 老年小鼠垂体D2 mRNA和蛋白水平低于年轻小鼠,证实垂体D2随年龄降低的假设。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: The DIO2 Thr92Ala polymorphism (rs225014), which occurs in about 15-30% of Caucasian people, determines a less efficient type 2 deiodinase (D2) enzyme. The aim of this study was to determine the impact of DIO2 Thr92Ala polymorphism on the serum thyrotropin (TSH) levels in thyroidectomized patients with hypothyroidism and to evaluate whether TSH levels and aging could be related, at pituitary level, to D2 activity. Methods: This prospective study was performed on 145 thyroid cancer patients, treated with total thyroidectomy, and undergoing radioiodine treatment after 3 weeks of levothyroxine (LT4) withdrawal. A mouse model has been used to determine D2 protein and mRNA levels in pituitary during aging. Results: Genetic analysis identified DIO2 Thr92Ala polymorphism in 56% of participants: 64/145 (44%) patients were homozygous wild type (WT) (Thr/Thr), 64 (44%) heterozygous (Thr/Ala), and 17 (12%) homozygous mutant (Ala/Ala). A significant negative relationship was observed between aging and the rise in serum TSH levels during LT4 withdrawal. However, this negative correlation found in WT was reduced in heterozygous and lost in mutant homozygous patients (Thr/Thr r = -0.45, p = 0.0002, 95% confidence interval [CI] -0.63 to -0.23; Ala/Thr r = -0.39, p = 0.0012, CI -0.60 to -0.67; and Ala/Ala r = -0.30, p = 0.2347; CI -0.70 to 0.20). Accordingly, when we compared the TSH measured in each patient to its theoretical value predicted from age, the TSH did not reach its putative target in 47% of WT patients, in 70% of Ala/Thr, and 76% of Ala/Ala carrying patients (p = 0.0036). This difference was lost in individuals older than 60 years, suggesting a decline of D2 associated with aging. The hypothesis that the pituitary D2 decreases with age was confirmed by the evidence that D2 mRNA and protein levels were lower in pituitary from old versus young mice. Conclusion: An age-related decline in TSH production in response to hypothyroidism was correlated with decreased D2 levels in pituitary. The presence of DIO2 homozygous Ala/Ala polymorphism was associated with a reduced level of TSH secretion in response to hypothyroidism, indicating a decreased pituitary sensitivity to serum thyroxine variation (Institutional Research Ethics board approval number no. 433/21).

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Luongo C, De Stefano MA, Ambrosio R, et al. Type 2 Deiodinase Thr92Ala Polymorphism and Aging Are Associated with a Decreased Pituitary Sensitivity to Thyroid Hormone. Thyroid. 2023. PMID: 36680751. doi:10.1089/thy.2022.0472

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。